On July 17, the offices of Senators Durbin (D. IL.), Warren (D. MA.), Sanders (I. VT.), and Welch (D. VT.) (collectively, “Senators”) released a report summarizing the results of a nine month investigation into...more
7/23/2025
/ Advertising ,
Anti-Kickback Statute ,
Data Privacy ,
Federal Trade Commission (FTC) ,
Healthcare ,
Healthcare Fraud ,
Investigations ,
Patient Access ,
Patient Privacy Rights ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Oversight ,
Telehealth
On December 11, 2024, a bill was introduced in the U.S. House of Representatives that, if enacted, would have substantial implications for pharmacy benefit managers (“PBMs”) and pharmacies across the country. Titled the...more
2/13/2025
/ Antitrust Division ,
Competition ,
Department of Justice (DOJ) ,
Drug Pricing ,
Federal Trade Commission (FTC) ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Monopolization ,
Pharmaceutical Industry ,
Pharmacies ,
Pharmacy Benefit Manager (PBM) ,
Proposed Legislation
On November 19, 2024, the Massachusetts Board of Registration in Pharmacy (the “Board”) published several memoranda that described the impending non-resident pharmacy licensure requirements and the anticipated timeline for...more